Lider-Burciulescu Sofia-Maria, Gheorghiu Monica, Braha Elena, Stanescu Laura Semonia, Patocs Attila, Badiu Corin
"Ana Aslan", National Institute of Geriatrics and Gerontology, Bucharest, Romania.
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
J Cell Mol Med. 2024 Dec;28(23):e70204. doi: 10.1111/jcmm.70204.
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours that originate from chromaffin cells and occur in the adrenal medulla and in the sympathetic or parasympathetic ganglia. Nearly 70% of PPGLs result from germline or somatic mutations in a single driver gene. The aim of this study was to characterize the genetic background and clinical characteristics related to genetic profile of patients with PPGLs from Romania. We retrospectively retrieved data of 125 patients consecutively registered, diagnosed with PPGLs in a tertiary referral center of endocrinology from Romania, between 1976 and 2022. We identified 88 (70.4%) women, and 37 (29.6%) men, with a mean age at diagnosis of 48.5 ± 15 years. From these 125 patients, 80 (64%) were submitted to the genomic study; 35% (n = 28) had a germline mutation (20 RET, 3 VHL, 1 SDHB, 1 NF1, 1 SDHD, 1 FANCA, 1 CASR) while 65% (n = 52) presented sporadic disease. Patients with hereditary disease had significantly lower age at diagnosis comparing to sporadic cases (37 ± 15 vs. 49.9 ± 12.2 years, p = 0.001). Bilateral tumors developed in twelve patients from the hereditary group. Metastatic disease was described in 4 out of 80 patients (2 of them with hereditary disease). Patients from sporadic group tended to have a right lateralisation of the tumour compared to hereditary cases, where the tumour was more often left sided. RET pathogenic variant (p.Cys634Trp) associated with MEN2A syndrome was the most prevalent in Romanian population with PPGLs and could be considered as a founder effect. Patients with hereditary disease are diagnosed at a younger age and develop bilateral tumors more frequently compared to sporadic cases.
嗜铬细胞瘤和副神经节瘤(PPGLs)是罕见的神经内分泌肿瘤,起源于嗜铬细胞,发生于肾上腺髓质以及交感或副交感神经节。近70%的PPGLs由单个驱动基因的种系或体细胞突变引起。本研究的目的是描述罗马尼亚PPGLs患者的遗传背景以及与基因谱相关的临床特征。我们回顾性检索了1976年至2022年间在罗马尼亚一家内分泌三级转诊中心连续登记诊断为PPGLs的125例患者的数据。我们确定其中有88名(70.4%)女性和37名(29.6%)男性,诊断时的平均年龄为48.5±15岁。在这125例患者中,80例(64%)接受了基因组研究;35%(n = 28)有生殖系突变(20例RET、3例VHL、1例SDHB、1例NF1、1例SDHD、1例FANCA、1例CASR),而65%(n = 52)表现为散发性疾病。与散发病例相比,遗传性疾病患者诊断时的年龄显著更低(37±15岁 vs. 49.9±12.2岁,p = 0.001)。遗传性组中有12例患者发生双侧肿瘤。80例患者中有4例出现转移性疾病(其中2例为遗传性疾病)。与遗传性病例相比,散发性组患者的肿瘤更倾向于右侧,而遗传性病例中肿瘤更常位于左侧。与MEN2A综合征相关的RET致病变体(p.Cys634Trp)在罗马尼亚PPGLs人群中最为普遍,可被视为一种奠基者效应。与散发病例相比,遗传性疾病患者诊断时年龄更小,双侧肿瘤的发生率更高。